{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T00:49:37Z","timestamp":1780447777651,"version":"3.54.1"},"reference-count":21,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,11]]},"DOI":"10.1097\/iop.0b013e3181b80cad","type":"journal-article","created":{"date-parts":[[2009,11,24]],"date-time":"2009-11-24T08:23:10Z","timestamp":1259050990000},"page":"430-433","source":"Crossref","is-referenced-by-count":32,"title":["Orbital Involvement in Langerhans Cell Histiocytosis"],"prefix":"10.1097","volume":"25","author":[{"given":"Houman","family":"Vosoghi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Rodriguez-Galindo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew W.","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-3-20210129","first-page":"88","article-title":"Histiocytosis X: a clinical study.","volume":"42","author":"Enriquez","year":"1967","journal-title":"Mayo Clin Proc"},{"key":"R2-3-20210129","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1002\/pbc.20364","article-title":"Predictors of outcome in children with Langerhans cell histiocytosis.","volume":"45","author":"Jubran","year":"2005","journal-title":"Pediatr Blood Cancer"},{"key":"R3-3-20210129","first-page":"208","article-title":"Writing Group of the Histiocyte Society.","volume":"1","year":"1987","journal-title":"Lancet"},{"key":"R4-3-20210129","first-page":"84","article-title":"Histiocytosis X: integration of eosinophilic granuloma of bone, Letterer-Siwe disease and Schuller-Christian disease as related manifestations of a single nosologic entity.","volume":"56","author":"Lichtenstein","year":"1953","journal-title":"AMA Arch Pathol"},{"key":"R5-3-20210129","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.critrevonc.2004.01.002","article-title":"Histiocyte disorders.","volume":"50","author":"Henter","year":"2004","journal-title":"Crit Rev Oncol Hematol"},{"key":"R6-3-20210129","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S0889-8588(05)70507-4","article-title":"Nosology and pathology of Langerans cell histiocytosis.","volume":"12","author":"Schmitz","year":"1998","journal-title":"Hematol Oncol Clin North Am"},{"key":"R7-3-20210129","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1056\/NEJM198910263211704","article-title":"The frequency and natural history of diabetes insipidus in children with Langerhans-cell histiocytosis.","volume":"321","author":"Dunger","year":"1989","journal-title":"N Engl J Med"},{"key":"R8-3-20210129","doi-asserted-by":"crossref","first-page":"2278","DOI":"10.1002\/(SICI)1097-0142(19990515)85:10<2278::AID-CNCR25>3.0.CO;2-U","article-title":"Langerhans cell histiocytosis: diagnosis, natural history, management, and outcome.","volume":"85","author":"Howarth","year":"1999","journal-title":"Cancer"},{"key":"R10-3-20210129","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1002\/mpo.2950170527","article-title":"Histiocytosis syndromes in children: II. Approach to the clinical and laboratory evaluation of children with Langerhans cell histiocytosis. Clinical Writing Group of the Histiocyte Society.","volume":"17","author":"Broadbent","year":"1989","journal-title":"Med Pediatr Oncol"},{"key":"R11-3-20210129","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1067\/mpd.2001.111331","article-title":"A randomized trial of treatment for multisystem Langerhans\u2019 cell histiocytosis.","volume":"138","author":"Gadner","year":"2001","journal-title":"J Pediatr"},{"key":"R12-3-20210129","doi-asserted-by":"crossref","first-page":"2556","DOI":"10.1182\/blood-2007-08-106211","article-title":"Improved outcome in multisystem Langerhans cell histiocytosis is associated with therapy intensification.","volume":"111","author":"Gadner","year":"2008","journal-title":"Blood"},{"key":"R13-3-20210129","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S0889-8588(05)70508-6","article-title":"Clinical aspects of Langerhans cell histiocytosis.","volume":"12","author":"Aric\u00f2","year":"1998","journal-title":"Hematol Oncol Clin North Am"},{"key":"R14-3-20210129","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.1002\/1097-0142(19951215)76:12<2471::AID-CNCR2820761211>3.0.CO;2-Z","article-title":"Langerhans\u2019 cell histiocytosis (histiocytosis X) of bone. A clinicopathologic analysis of 263 pediatric and adult cases.","volume":"76","author":"Kilpatrick","year":"1995","journal-title":"Cancer"},{"key":"R15-3-20210129","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1136\/adc.75.1.17","article-title":"A multicentre retrospective survey of Langerhans\u2019 cell histiocytosis: 348 cases observed between 1983 and 1993. The French Langerhans\u2019 Cell Histiocytosis Study Group.","volume":"75","year":"1996","journal-title":"Arch Dis Child"},{"key":"R16-3-20210129","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1002\/mpo.2950230203","article-title":"Treatment strategy for disseminated Langerhans cell histiocytosis. DAL HX-83 Study Group.","volume":"23","author":"Gadner","year":"1994","journal-title":"Med Pediatr Oncol"},{"key":"R17-3-20210129","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.ajo.2005.08.029","article-title":"Langerhans cell histiocytosis of the orbit: a need for interdisciplinary dialogue.","volume":"141","author":"Harris","year":"2006","journal-title":"Am J Ophthalmol"},{"key":"R18-3-20210129","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1002\/mpo.2950080106","article-title":"Quality of survival in histiocytosis X: a Southwest Oncology Group study.","volume":"8","author":"Komp","year":"1980","journal-title":"Med Pediatr Oncol"},{"key":"R19-3-20210129","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1002\/mpo.2950110206","article-title":"Histiocytosis X in children: patterns of disease and results of treatment.","volume":"11","author":"Matus-Ridley","year":"1983","journal-title":"Med Pediatr Oncol"},{"key":"R20-3-20210129","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1136\/adc.65.3.301","article-title":"Langerhans cell histiocytosis: the case for conservative treatment.","volume":"65","author":"McLelland","year":"1990","journal-title":"Arch Dis Child"},{"key":"R21-3-20210129","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1002\/pbc.20760","article-title":"Central nervous system-related permanent consequences in patients with Langerhans cell histiocytosis.","volume":"48","author":"Mittheisz","year":"2007","journal-title":"Pediatr Blood Cancer"},{"key":"R22-3-20210129","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.jpeds.2007.12.042","article-title":"Pattern and course of neurodegeneration in Langerhans cell histiocytosis.","volume":"153","author":"Wnorowski","year":"2008","journal-title":"J Pediatr"}],"container-title":["Ophthalmic Plastic &amp; Reconstructive Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/IOP.0b013e3181b80cad","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T01:43:27Z","timestamp":1620956607000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00002341-200911000-00003"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,11]]},"references-count":21,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.1097\/iop.0b013e3181b80cad","relation":{},"ISSN":["0740-9303"],"issn-type":[{"value":"0740-9303","type":"print"}],"subject":[],"published":{"date-parts":[[2009,11]]}}}